The best Bull and Bear pitches based on recency and number of recommendations.
If there's a thesis for buying Alcobra, it must be that the company will achieve success in the second go round phase III trial of MDX for adult ADHD (are we sure this is a real disease?). This is a rather tough sell given failure in the first phase… More
Read the most recent pitches from players about ADHD.DL.
Find the members with the highest scoring picks in ADHD.DL.
See what the Wall Street professionals think, according to their public statements and filings.